Author:
Kanaya Takahiro,Nakae Ryuta,Sekine Tetsuro,Fujiki Yu,Takayama Yasuhiro,Igarashi Yutaka,Suzuki Go,Naoe Yasutaka,Yokota Hiroyuki,Yokobori Shoji
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Allard CB, Scarpelini S, Rhind SG, Baker AJ, Shek PN, Tien H, Fernando M, Tremblay L, Morrison LJ, Pinto R, Rizoli SB (2009) Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma 67:959–967
2. Association for the Advancement of Automotive Medicine (1998) The Abbreviated Injury Scale (AIS) 1998 Revision. Des Plaines, Illinois
3. Brenner A, Belli A, Chaudhri R, Coats T, Frimley L, Jamaluddin SF, Jooma R, Mansukhani R, Sandercock P, Shakur-Still H, Shokunbi T, Roberts I, CRASH-3 trial collaborators (2020) Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial. Crit Care 24:560
4. Chen H, Chen M (2020) The efficacy of tranexamic acid for brain injury: a meta-analysis of randomized controlled trials. Am J Emerg Med 38:364–370
5. CRASH-3 Trial Collaborators (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713–1723